Zhang et al., reported E-cad promoter methylation was linked to a decrease in expression of E-cad protein, in AdCC patients, indicating methylation of E-cad causes a dysregulation of E-cad protein [28]. This evidence concerns the gene CDH1 and adrenocortical carcinoma, hereditary.